More Hemlibra Deaths

Updated: Jul 22, 2020

Genentech released the quarterly fatalities report for Emicizumab (Hemlibra) and there are now 34 reported deaths. This makes it the most reported deaths for a Hemophilia product since FDA approval.


HemoAware has been the only organization to report this news to the community since it's entry into the market.


https://www.emicizumabinfo.com/content/dam/gene/emicizumabinfo/patient/pdfs/reported-fatalities.pdf





0 comments

Recent Posts

See All